COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1486: Articles 14851-14860  | Next

The effect of Health Literacy on COVID-19 Vaccine Hesitancy: The Moderating Role of Stress
Zhang, F., Zhang, H., Li, Y., Peng, S., Jiang, Y., Jin, H.
10.1101/2021.06.16.21258808 — Posted: 2021-06-24
Optimal Selection of COVID-19 Vaccination Sites at the Municipal Level
Cabanilla, K. I. M., Enriquez, E. A. T., Mendoza, R., Mendoza, V. M. P.
10.1101/2021.06.20.21259194 — Posted: 2021-06-24
Delay of molecular SARS-CoV-2 testing and turnaround time in Mexico and Colombia
Nunez, I., Belaunzaran-Zamudio, P. F., Caro-Vega, Y.
10.1101/2021.06.16.21259046 — Posted: 2021-06-24 Discussion: Onsite
Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic
Gibbs, H., Waterlow, N. R., Cheshire, J., Danon, L., Liu, Y., Grundy, C., Kucharski, A. J., LSHTM CMMID COVID-19 Working Group, , Eggo, R. M.
10.1101/2021.06.22.21259336 — Posted: 2021-06-24
Correlates of Protection against symptomatic and asymptomatic SARS-CoV-2 infection
Feng, S., Phillips, D., White, T., Sayal, H., Aley, P. K., Bibi, S., Dold, C., Fuskova, M., Gilbert, S. C., Hirsch, I., Humphries, H. E., Jepson, B., Kelly, E. J., Plested, E., Shoemaker, K., Thomas, K. M., Vekemans, J., Villafana, T. L., Lambe, T., Pollard, A. J., Voysey, M., Oxford Vaccine Trial Team
10.1101/2021.06.21.21258528 — Posted: 2021-06-24 Discussion: Onsite
Trends in COVID-19 vaccination intent, determinants and reasons for vaccine hesitancy: results from repeated cross-sectional surveys in the adult general population of Greece during November 2020-June 2021
Sypsa, V., Roussos, S., Engeli, V., Paraskevis, D., Tsiodras, S., Hatzakis, A.
10.1101/2021.06.23.21259376 — Posted: 2021-06-24
Selective tweeting of COVID-19 articles: Does title or abstract positivity influence dissemination?
Fabiano, N., Hallgrimson, Z., Wong, S., Salameh, J.-P., Kazi, S., Unni, R. R., Treanor, L., Frank, R., Prager, R., McInnes, M. D.
10.1101/2021.06.22.21259354 — Posted: 2021-06-24
Validation of the 4C Deterioration Model for COVID-19 in a UK teaching hospital during Wave 2
Cowan, S. L., Wiegand, M., Preller, J., Goudie, R. J. B.
10.1101/2021.06.22.21259331 — Posted: 2021-06-24
The Influence of Public Health Faculty on College and University Plans during the COVID-19 Pandemic
Johnson, D. A., Cahill, M., Choate, S., Roelfs, D., Walsh, S. E.
10.1101/2021.06.23.449583 — Posted: 2021-06-23
First identification of SARS-CoV-2 Lambda (C.37) variant in Southern Brazil
Wink, P. L., Volpato, F. C. Z., Monteiro, F. L., Willig, J. B., Zavascki, A. P., Barth, A. L., Martins, A. F.
10.1101/2021.06.21.21259241 — Posted: 2021-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).